Circulating Tumor Microemboli Diagnostics for Patients With Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology - United States
doi 10.1097/jto.0000000000000235
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Circulating Tumor Cells as a Prognostic Factor in Patients With Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2014English

Tumor Evolution in Non-Small-Cell Lung Cancer

ESMO Open
Cancer ResearchOncology
2018English

Circulating Microparticles Are Prognostic Biomarkers in Advanced Non-Small Cell Lung Cancer Patients

Oncotarget
Oncology
2017English

Small Cell Lung Cancer: Model of Circulating Tumor Cell Tumorospheres in Chemoresistance

Scientific Reports
Multidisciplinary
2017English

Circulating Tumor Cells as a Screening and Diagnostic Marker for Early-Stage Non-Small Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2020English

Detection of PD-L1 Expression and Its Clinical Significance in Circulating Tumor Cells From Patients With Non-Small-Cell Lung Cancer

Cancer Management and Research
Oncology
2020English

Circulating CD14+CD204+ Cells Predict Postoperative Recurrence in Non–Small-Cell Lung Cancer Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2014English

Comparison of Primary Tumor SUVmax Between Small Cell Lung Cancer and Non-Small Cell Lung Cancer

Current Trends in Clinical & Medical Imaging
2019English

Small Cell Lung Cancer: Recruitment of Macrophages by Circulating Tumor Cells

OncoImmunology
OncologyAllergyImmunology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy